Logo
Menu
  • Home
  • Practice Areas
    • Medical Malpractice LawHelping New York Medical Malpractice, Personal Injury Cases
    • Close
  • New York Injury News
  • Press release
    • Injury News
    • Motor Vehicle Accidents
    • Personal Injury Accidents
    • Construction Accidents
    • Medical Malpractice
    • Premises Liability
    • Product Liability
    • Work Related Fire Fighter Deaths
    • Wrongful Death
    • Close
  • Ask A Lawyer
  • Free Case Evaluation
  • Sitemap

Home » Injury News » Recall: Bristol-Myers Squibb recalls blister packs of Coumadin® 1 mg tablets

Recall: Bristol-Myers Squibb recalls blister packs of Coumadin® 1 mg tablets

New Source: JusticeNewsFlash.com
07/14/2010 // WPB, FL, USA // Nicole Howley // Nicole Howley

West Palm Beach, FL—A voluntary recall of 3 lots of physician sample blister packs of Coumadin® 1 mg tablets and 5 lots, of Coumadin 1 mg tablet hospital unit dose (HUD) blister packs, has been initiated by Bristol-Myers Squibb. The U.S. Food and Drug Administration (FDA) released the recall on July 12, 2010.

The recall included: Physician Sample Blister Packs: Lot# 9A48931A, 9A48931B, 9A48931C, expiration January 2012; HUD Blister Pack: Lot# 8F34006B, 8K44272A, 8K46168A, 9F44437A and 9K58012B with expiry dates between June 2011 and November 2012.

The recall was initiated as a precautionary measure after Bristol-Myers Squibb determined that some of the tablets, over a period of time, would not meet the specification for isopropanol. This could affect the therapeutic levels of the active ingredient, Coumadin.

The FDA press release stated, “Coumadin is prescribed to treat or prevent blood clots. A decrease of active ingredient may increase the risk of clots which could lead to heart attack or stroke and if there is too much active ingredient, there is an increased risk of bleeding.”

“The recall only involves Coumadin 1 mg tablet blister-packs distributed in the U.S. This recall does not involve Coumadin 1 mg supplied in bottles or any other strengths and dosage forms of the product. Patients who may have product from the subject lots should contact their physicians to ensure that their anticoagulation therapy is not interrupted.”

Any adverse reactions can be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov.

Consumers and healthcare professionals can obtain more information about the recall at:

• Recall Logistics: Stericycle 1-877-546-0128

• General Inquiries: Bristol-Myers Squibb Customer Relations, 1-800-332-2056 (option 1, then option 4)

• Medical Inquiries: Bristol-Myers Squibb Medical Information, 1-800-321-1335 (option 5)

• Recall Reimbursement Process: Bristol-Myers Squibb Customer Service Operations, 1-800-631-5244 (option 1, then option 5)

Legal News Reporter: Nicole Howley-Legal news for product safety attorneys.

Media Information:

Address:
Phone: 866-598-1315
Url: http://NicoleHowley.visionsmartnews.com/recall-bristol-myers-squibb-recalls-blister-packs-of-coumadin-1-mg-tablets_1352.html News Source: JusticeNewsFlash.com – Press Release Distribution

It's only fair to share...Pin on Pinterest
Pinterest
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Email this to someone
email
Print this page
Print
July 20, 2010   injurynewsreporter
Injury News
×

  • Chicago IL Street Race Took Deadly Turn When Driver Lost Control on I-290
  • CPSC Recall: Wire feed welders pose burn hazards, Star Asia USA recalls product

Recent News and Press Coverage

  • Todd Stager, Esteemed SEO for Lawyers Expert, Embarks on a New Journey with His Own SEO Firm March 11, 2024
  • Attorney Dan Powell Examines the Financial Challenges of Not Having a Living Trust: Implications for Business Owners February 16, 2024
  • Adam P. Boyd Leads Innovative Masterclass on Strategies for Law Firm Growth February 14, 2024
  • David Dardashti Donates to Expand Research on Sexual Violence Among Children and Develop Prevention Protocol. January 29, 2024
  • A Queens County Supreme Court jury rendered a verdict for $7 million In Medical Negligence Case December 1, 2023
  • Record-Breaking $700,000 Verdict by Mezrano Law Firm Redefines Justice in Personal Injury Cases November 30, 2023
  • The Law Office of Richard Roman Shum Unveils Comprehensive Guide on New York Divorce Laws October 12, 2023
  • Brooklyn Estate Planning Attorney Yana Feldman Offers Free Services for Israel-bound Volunteers October 12, 2023
  • Google Drops FAQ Rich Snippets so Custom Legal Marketing Released a Video to Help Lawyers Understand Why October 5, 2023
  • Bronx Injury Attorneys Explain How Damages Are Calculated August 22, 2023
  • ZeroRisk Cases, Inc. Utilizes Cutting-Edge Technology to Target High-Quality Plaintiffs in Talcum Powder Litigation August 15, 2023
  • ZeroRisk Cases, Inc. Unveils Advanced Website Platform and Digital Marketing Strategy for Increased Law Firm Growth August 15, 2023
  • The Search Engine Domination Society Achieves a 300% Increase in Client Calls for NYC Personal Injury Lawyer August 11, 2023
  • Federal Tax Credits ERC Updates and Releases New Informational Videos about ERC July 6, 2023
  • Who is Liable for Dooring Accidents? Bronx E-bike Attorney Glenn A. Herman Explains July 4, 2023
  • Weizhen Tang Announces Publication of Law and Justice: My Struggle During His 2026 Mayoral Campaign July 4, 2023
  • Enhancing Data Compliance with AdvisorVault: Heritage Brokerage’s 17a-4 Trusted Partner July 3, 2023
  • Attorney Beau Harlan: The Champion of Justice Unveils Comprehensive Legal Services for Vancouver, WA and Portland, OR June 28, 2023
  • The Legal Process for Motor Vehicle Accidents in New York City June 2, 2023
  • NYC Bicycle Accident Lawyer Explains Winning an Accident Claim March 20, 2023

Archives

  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • July 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • December 1999
  • January 1970
New York Injury News
1512 Schorr Place
PMB #35071
Bronx, NY 10469
718-210-1007
Copyright © 2025 New York Injury News
Go to mobile version